INTAS Pharma gets DGCI nod for clinical trial of its newly developed COVID-19 drug
New Delhi, 30 August 2020: Intas pharmceuticals has announced that its R&D team has developed a COVID-19 specific Hyperimmune Globulin as treatment for…
Explore the topic
News
The latest reporting, perspectives and analysis from our editorial desk.
-
-
IIT Alumni Council withdraws from vaccine development race; says hastened approach may have long-term safety implications
New Delhi, 24 August, 2020: IIT Alumni Council which is a global body of alumni, students and academicians across Indian Institutes of Technology in…
-
Castrol India exceeds CSR target; major focus on truck drivers and mechanics
New Delhi, 13 August 2020: India’s second largest manufacturer of automotive and industrial lubricants, Castrol India has exceeded its CSR budget in the…
-
CSR 2019-20: HDFC increases CSR spend by 20%; Spends Rs 535 Crore
New Delhi, 1 August 2020: India’s leading banking company HDFC spent a total of Rs535 Cr on various CSR activities in the year 2019-20, an increase of 20%…
-
Cyclone Amphan: Coca-Cola India partners with Save the Children for relief works in West Bengal
New Delhi, 7th July 2020: Coca-Cola in India has partnered with Save the Children to address the food security and shelter needs of affected victims of…
-
Covid-19: Coca-Cola, CARE India join hands to offer relief to over 1.5 lakh marginalised
New Delhi, 17 June 2020: With a focus towards supporting relief operations during the COVID-19 pandemic, Coca-Cola has partnered with CARE India to…
